The tools to end new HIV infections and AIDS exist. The knowledge on how to use them is agreed upon. Nevertheless late diagnosis of HIV remains a challenges across the European Union and European Economic Area.
From diagnosis of HIV to successful viral suppression: in a rapid communication published in Eurosurveillance, ECDC and co-authors from Public Health England and The National AIDS Trust summarise the progress towards HIV elimination in 52 countries in Europe and Central Asia. The main issues: diagnosing those who are unaware of their HIV infection and treating them.
With nearly 160 000 people newly diagnosed with HIV, 2017 marked another year of alarming numbers of new HIV diagnoses in the WHO European Region. In contrast, the European Union and European Economic Area (EU/EEA) countries reported a decline in rates of new diagnoses, mainly driven by a 20% decrease since 2015 among men who have sex with men.
Since the latest ECDC-EFSA rapid outbreak assessment published on 12 December 2017, 15 EU/EEA countries (Belgium, Czech Republic, Denmark, France, Hungary, Iceland, Ireland, Italy, Luxembourg, Netherlands, Norway, Poland, Slovenia, Sweden and United Kingdom) have reported 336 confirmed, 94 probable and 3 new historical-confirmed cases associated with this ongoing multi-country outbreak of Salmonella Enteritidis in the EU/EEA.
Since May 2018 and as of 10 November 2018, there have been 329 Ebola virus disease cases (294 confirmed, 35 probable), including 205 deaths (170 of which were confirmed cases).
Since May 2018 and as of 24 October 2018, there have been 251 Ebola virus disease cases (216 confirmed, 35 probable), including 162 deaths (127 of which were confirmed cases).
Since 11 May and as of 8 September 2018, 131 Ebola cases were reported in the Democratic Republic of Congo (DRC), of which 100 are confirmed and 31 probable. Among the 131 cases, 90 had a fatal outcome. Eight health zones in two provinces have reported confirmed and probable EVD cases, including Mabalako, Beni, Butembo, Oicha, Masereka, Kalungata and Musienene health zones in North Kivu Province and Mandima Health Zone in Ituri Province.
Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).